In a univariable analysis, ERFE expression was significantly associated with inferior overall survival (OS) and disease-specific survival (DSS) in n = 10 tumor types as well as inferior progression-free interval (PFI) in n = 11 tumor types (Figure 2A). This evidence concerns the gene ERFE and neoplasm.